glp-1 euglycemic dka Drugs and Type 1 Diabetes: Less Insulin, Better Time in Range — What the Evidence Combining glucagon-like peptide-1 receptor agonists

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin

Leading diabetologist Rajiv Kovil says that India is price sensitive, but at the same time an aspirational market, and there will be a place for both innovators and generics

The GLP-1s have multi-organ protective therapies with benefits spanning cardiovascular, kidney, liver, metabolic, and emerging neurologic domains as well

doi: 10.1152/ajprenal.00464.2009 88 MendisBSimpsonEMacDonaldIMansellP

Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium

The patient developed high creatine levels and serious kidney injury during the weeks after surgery